ATE79630T1 - Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. - Google Patents

Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.

Info

Publication number
ATE79630T1
ATE79630T1 AT88402476T AT88402476T ATE79630T1 AT E79630 T1 ATE79630 T1 AT E79630T1 AT 88402476 T AT88402476 T AT 88402476T AT 88402476 T AT88402476 T AT 88402476T AT E79630 T1 ATE79630 T1 AT E79630T1
Authority
AT
Austria
Prior art keywords
group
image
carbon atoms
hydroxy
lower alkyl
Prior art date
Application number
AT88402476T
Other languages
English (en)
Inventor
Francois-Xavier Jarreau
Jean-Jacques Koenig
Original Assignee
Nativelle Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nativelle Lab filed Critical Nativelle Lab
Application granted granted Critical
Publication of ATE79630T1 publication Critical patent/ATE79630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
AT88402476T 1987-10-02 1988-09-30 Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. ATE79630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8713658A FR2621316B1 (fr) 1987-10-02 1987-10-02 Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant
EP88402476A EP0310519B1 (de) 1987-10-02 1988-09-30 Androstan-17-carbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten

Publications (1)

Publication Number Publication Date
ATE79630T1 true ATE79630T1 (de) 1992-09-15

Family

ID=9355472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88402476T ATE79630T1 (de) 1987-10-02 1988-09-30 Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.

Country Status (22)

Country Link
US (1) US4885280A (de)
EP (1) EP0310519B1 (de)
JP (1) JP2783560B2 (de)
KR (1) KR970002642B1 (de)
AT (1) ATE79630T1 (de)
AU (1) AU607100B2 (de)
CA (1) CA1306248C (de)
DE (1) DE3873870T2 (de)
DK (1) DK165595C (de)
EG (1) EG19114A (de)
ES (1) ES2052761T3 (de)
FI (1) FI89055C (de)
FR (1) FR2621316B1 (de)
GR (1) GR3005968T3 (de)
HK (1) HK60297A (de)
IE (1) IE61941B1 (de)
IL (1) IL87894A (de)
MY (1) MY103635A (de)
NO (1) NO173011C (de)
NZ (1) NZ226433A (de)
PT (1) PT88648B (de)
ZA (1) ZA887396B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
WO1993005790A1 (en) * 1991-09-27 1993-04-01 Procter & Gamble Pharmaceuticals, Inc. Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure
CZ331094A3 (en) * 1992-06-26 1995-09-13 Pfizer Steroidal glycosides and their use for treating hypercholesterolemia and atherosclerosis
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
PL313620A1 (en) * 1993-09-24 1996-07-08 Procter & Gamble Novel 14-aminosteroid compounds containing oligosaccharides and novel process of diastereoselective chemistry of steroids
CN1135757A (zh) * 1993-09-24 1996-11-13 普罗克特和甘保尔公司 新型含脱氧和氧被取代的糖的14-氨基类固醇
AU700131B2 (en) * 1993-09-24 1998-12-24 Procter & Gamble Company, The Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
BR9709835A (pt) * 1996-06-17 1999-08-10 Procter & Gamble Compostos 14-aminoesteróides contendo açúcar substituído com deóxi e oxigênio para uso como um antiarrítmico
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
EP3827747A1 (de) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharmainformatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
GB201112402D0 (en) 2011-07-19 2011-08-31 British American Tobacco Co Cellulose acetate compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
US3634409A (en) * 1966-04-26 1972-01-11 Syntex Corp 3beta-tetrahydrofuran-2'-yloxy-delta**4-steroids of the androstane and estrane series
FR2464270A1 (fr) * 1979-08-31 1981-03-06 Nativelle Sa Ets Nouveaux derives d'amino-14 steroides, et procede pour leur preparation
ES8404694A1 (es) * 1982-08-20 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
NZ205293A (en) * 1982-08-20 1986-12-05 Nativelle Sa Ets 14-aminosteroids and pharmaceutical compositions

Also Published As

Publication number Publication date
IL87894A (en) 1994-02-27
FR2621316A1 (fr) 1989-04-07
NO884344D0 (no) 1988-09-30
ES2052761T3 (es) 1994-07-16
DK549388A (da) 1989-04-03
PT88648A (pt) 1988-10-01
US4885280A (en) 1989-12-05
FI884511A0 (fi) 1988-09-30
FR2621316B1 (fr) 1991-06-21
EP0310519B1 (de) 1992-08-19
IL87894A0 (en) 1989-03-31
EG19114A (fr) 1994-07-30
IE61941B1 (en) 1994-11-30
DK165595B (da) 1992-12-21
HK60297A (en) 1997-05-16
NO884344L (no) 1989-04-03
NZ226433A (en) 1991-06-25
EP0310519A1 (de) 1989-04-05
MY103635A (en) 1993-08-28
FI884511A (fi) 1989-04-03
KR970002642B1 (ko) 1997-03-07
NO173011C (no) 1993-10-13
PT88648B (pt) 1992-12-31
IE882991L (en) 1989-04-02
FI89055C (fi) 1993-08-10
DK549388D0 (da) 1988-09-30
KR890006667A (ko) 1989-06-15
DK165595C (da) 1993-05-03
DE3873870T2 (de) 1993-02-18
JP2783560B2 (ja) 1998-08-06
DE3873870D1 (de) 1992-09-24
JPH01156995A (ja) 1989-06-20
ZA887396B (en) 1991-11-27
GR3005968T3 (de) 1993-06-07
AU607100B2 (en) 1991-02-21
AU2293588A (en) 1989-04-06
CA1306248C (en) 1992-08-11
FI89055B (fi) 1993-04-30
NO173011B (no) 1993-07-05

Similar Documents

Publication Publication Date Title
ATE79630T1 (de) Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
RU97101087A (ru) Применение соединений стерина для получения лекарственного средства, регулирующего мейоз и способ регулирования мейоза
DE69023947D1 (de) Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
DE69020781D1 (de) Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
ATE43840T1 (de) Heterocyclische stickstoffverbindungen, ihre herstellung und heilmittel die sie enthalten.
DK163055C (da) Analogifremgangsmaade til fremstilling af 2-dipropylamino-(5 eller 7)-formylamino-6-hydroxy-1,2,3,4-tetrahydronaphthalen og farmakologisk acceptable syreadditionssalte deraf
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ATE28077T1 (de) Aminoderivate von in stellung 6 durch ein heterocyclisch oder ein alicyclisch substituiertes pyridazin, verfahren zu deren herstellung und heilmittel die sie enthalten.
ATE11912T1 (de) ((indol-3-yl)-3-amino-2-propionyloxy)-2essigs|urederivate, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
ATE20063T1 (de) 3-pyridyl-5-alkoxy(oder phenoxy- oder aralkyloxy- )pyrazol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE81126T1 (de) Benzopyrrolidinon-derivate, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
DE69306513T2 (de) Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
ATE77379T1 (de) Neue imidazo- und triazolothiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte.
ES8303405A1 (es) Procedimiento de preparacion de derivados de quinidina.
PT75900A (de) Neue oxyme von 3'''-dehydro-cardenolid-trididitoxosiden verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3415100A1 (de) Neue 2,3-diamino-2,3-didesoxyhexosederivate, verfahren zu ihrer herstellung und ihre verwendung
ATE2222T1 (de) Digoxin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
SE7806445L (sv) Alkanolaminderivat och sett for deras framstellning

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee